{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:02:57Z","timestamp":1789516977979,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04474-5","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:06:07Z","timestamp":1782731167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Silencing of ELFN1-AS1 induces prostate cancer cell apoptosis and autophagy by regulating miR-28-5p\/BCAM axis"],"prefix":"10.1186","volume":"24","author":[{"given":"Shuai","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingwen","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yankuang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"4474_CR1","doi-asserted-by":"crossref","unstructured":"Yang S, Ye Z, Ning J, Wang P, Zhou X, Li W et al. Cholesterol metabolism and urinary system tumors. Biomedicines. 2024;12(8):1832.","DOI":"10.3390\/biomedicines12081832"},{"issue":"2","key":"4474_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O, et al. 2022 update on prostate cancer epidemiology and risk factors-a systematic review. Eur Urol. 2023;84(2):191\u2013206.","journal-title":"Eur Urol"},{"issue":"41","key":"4474_CR3","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.15585\/mmwr.mm6941a1","volume":"69","author":"DA Siegel","year":"2020","unstructured":"Siegel DA, O\u2019Neil ME, Richards TB, Dowling NF, Weir HK. Prostate cancer incidence and survival, by stage and race\/ethnicity - United States, 2001\u20132017. MMWR Morb Mortal Wkly Rep. 2020;69(41):1473\u201380.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"4474_CR4","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1002\/ijc.33045","volume":"147","author":"S Remmers","year":"2020","unstructured":"Remmers S, Roobol MJ. Personalized strategies in population screening for prostate cancer. Int J Cancer. 2020;147(11):2977\u201387.","journal-title":"Int J Cancer"},{"issue":"6","key":"4474_CR5","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.mcna.2020.08.007","volume":"104","author":"SV Carlsson","year":"2020","unstructured":"Carlsson SV, Vickers AJ. Screening for prostate cancer. Med Clin North Am. 2020;104(6):1051\u201362.","journal-title":"Med Clin North Am"},{"issue":"3","key":"4474_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","volume":"80","author":"LF Valle","year":"2021","unstructured":"Valle LF, Lehrer EJ, Markovic D, Elashoff D, Levin-Epstein R, Karnes RJ, et al. A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER). Eur Urol. 2021;80(3):280\u201392.","journal-title":"Eur Urol"},{"key":"4474_CR7","doi-asserted-by":"crossref","unstructured":"Saouli A, Ruffion A, Dariane C, Barret E, Fiard G, Hankard GF et al. Salvage radical prostatectomy for recurrent prostate cancer: a systematic review (French ccAFU). Cancers. 2023;15(22):5485.","DOI":"10.3390\/cancers15225485"},{"key":"4474_CR8","doi-asserted-by":"crossref","unstructured":"Wang F, Luan Y, Fan Y, Huang T, Zhu L, Lu S et al. Comparison of the oncological and functional outcomes of brachytherapy and radical prostatectomy for localized prostate cancer. Med (Kaunas). 2022;58(10):1387.","DOI":"10.3390\/medicina58101387"},{"issue":"6","key":"4474_CR9","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nrclinonc.2014.68","volume":"11","author":"AJ Chang","year":"2014","unstructured":"Chang AJ, Autio KA, Roach M 3rd, Scher HI. High-risk prostate cancer-classification and therapy. Nat Rev Clin Oncol. 2014;11(6):308\u201323.","journal-title":"Nat Rev Clin Oncol"},{"key":"4474_CR10","doi-asserted-by":"publisher","first-page":"103543","DOI":"10.1016\/j.critrevonc.2021.103543","volume":"169","author":"RL Wilson","year":"2022","unstructured":"Wilson RL, Taaffe DR, Newton RU, Hart NH, Lyons-Wall P, Galv\u00e3o DA. Obesity and prostate cancer: a narrative review. Crit Rev Oncol Hematol. 2022;169:103543.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"19","key":"4474_CR11","doi-asserted-by":"publisher","first-page":"e108863","DOI":"10.15252\/embj.2021108863","volume":"40","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky DJ, Petroni G, Amaravadi RK, Baehrecke EH, Ballabio A, Boya P, et al. Autophagy in major human diseases. Embo j. 2021;40(19):e108863.","journal-title":"Embo j"},{"issue":"10","key":"4474_CR12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41419-023-06154-8","volume":"14","author":"S Liu","year":"2023","unstructured":"Liu S, Yao S, Yang H, Liu S, Wang Y, Autophagy. Regulator of cell death. Cell Death Dis. 2023;14(10):648.","journal-title":"Cell Death Dis"},{"issue":"6","key":"4474_CR13","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/cbin.11137","volume":"43","author":"MS D\u2019Arcy","year":"2019","unstructured":"D\u2019Arcy MS. Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int. 2019;43(6):582\u201392.","journal-title":"Cell Biol Int"},{"issue":"16","key":"4474_CR14","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1002\/cncr.31335","volume":"124","author":"AV Onorati","year":"2018","unstructured":"Onorati AV, Dyczynski M, Ojha R, Amaravadi RK. Targeting autophagy in cancer. Cancer. 2018;124(16):3307\u201318.","journal-title":"Cancer"},{"key":"4474_CR15","doi-asserted-by":"crossref","unstructured":"Taniue K, Akimitsu N. The functions and unique features of LncRNAs in cancer development and tumorigenesis. Int J Mol Sci. 2021;22(2):632.","DOI":"10.3390\/ijms22020632"},{"issue":"2","key":"4474_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4474_CR17","doi-asserted-by":"crossref","unstructured":"Chi Y, Wang D, Wang J, Yu W, Yang J. Long non-coding rna in the pathogenesis of cancers. Cells. 2019;8(9):1015.","DOI":"10.3390\/cells8091015"},{"key":"4474_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.canlet.2019.08.010","volume":"464","author":"YH Xu","year":"2019","unstructured":"Xu YH, Deng JL, Wang G, Zhu YS. Long non-coding RNAs in prostate cancer: Functional roles and clinical implications. Cancer Lett. 2019;464:37\u201355.","journal-title":"Cancer Lett"},{"issue":"1","key":"4474_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.31557\/APJCP.2021.22.1.111","volume":"22","author":"M Bagheri","year":"2021","unstructured":"Bagheri M, Khansarinejad B, Mosayebi G, Moradabadi A, Mondanizadeh M. Diagnostic Value of Plasma miR-145 and miR-185 as Targeting of the APRIL Oncogene in the B-cell Chronic Lymphocytic Leukemia. Asian Pac J Cancer Prev. 2021;22(1):111\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"key":"4474_CR20","doi-asserted-by":"crossref","unstructured":"Qin X, Zhong J, Wang L, Chen Z, Liu X. LncRNA LNC-565686 promotes proliferation of prostate cancer by inhibiting apoptosis through stabilizing SND1. Biomedicines. 2023;11(10):2627.","DOI":"10.3390\/biomedicines11102627"},{"key":"4474_CR21","doi-asserted-by":"publisher","first-page":"101807","DOI":"10.1016\/j.tranon.2023.101807","volume":"39","author":"F Zeng","year":"2024","unstructured":"Zeng F, Li D, Kang X, Wu Q, Song M, Ou Z, et al. MALAT1 promotes FOXA1 degradation by competitively binding to miR-216a-5p and enhancing neuroendocrine differentiation in prostate cancer. Transl Oncol. 2024;39:101807.","journal-title":"Transl Oncol"},{"issue":"1","key":"4474_CR22","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1515\/med-2022-0582","volume":"17","author":"S Peng","year":"2022","unstructured":"Peng S, Luo Y, Chen L, Dai K, Wang Q. lncRNA ELFN1-AS1 enhances the progression of colon cancer by targeting miR-4270 to upregulate AURKB. Open Med (Wars). 2022;17(1):1999\u20132012.","journal-title":"Open Med (Wars)"},{"key":"4474_CR23","doi-asserted-by":"publisher","first-page":"806682","DOI":"10.3389\/fphar.2022.806682","volume":"13","author":"X Jing","year":"2022","unstructured":"Jing X, Du L, Shi S, Niu A, Wu J, Wang Y, et al. Hypoxia-induced upregulation of lncRNA ELFN1-AS1 promotes colon cancer growth and metastasis through targeting TRIM14 via sponging miR-191-5p. Front Pharmacol. 2022;13:806682.","journal-title":"Front Pharmacol"},{"issue":"4","key":"4474_CR24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3233\/CBM-210393","volume":"34","author":"B Yang","year":"2022","unstructured":"Yang B, Miao S. lncRNA ELFN1-AS1 predicts poor prognosis and promotes tumor progression of non-small cell lung cancer by sponging miR-497. Cancer Biomark. 2022;34(4):637\u201346.","journal-title":"Cancer Biomark"},{"issue":"3","key":"4474_CR25","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3724\/abbs.2023023","volume":"55","author":"J Huang","year":"2023","unstructured":"Huang J, Yuan W, Chen B, Li G, Chen X. lncRNA ELFN1-AS1 upregulates TRIM29 by suppressing miR-211-3p to promote gastric cancer progression. Acta Biochim Biophys Sin (Shanghai). 2023;55(3):484\u201397.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"4474_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jare.2024.01.028","volume":"67","author":"Y Chen","year":"2025","unstructured":"Chen Y, Shen J, Yuan M, Li H, Li Y, Zheng S, et al. Dehydrocostus lactone suppresses gastric cancer progression by targeting ACLY to inhibit fatty acid synthesis and autophagic flux. J Adv Res. 2025;67:331\u201348.","journal-title":"J Adv Res"},{"issue":"19","key":"4474_CR27","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1016\/j.jmb.2012.11.024","volume":"425","author":"JH Yoon","year":"2013","unstructured":"Yoon JH, Abdelmohsen K, Gorospe M. Posttranscriptional gene regulation by long noncoding RNA. J Mol Biol. 2013;425(19):3723\u201330.","journal-title":"J Mol Biol"},{"issue":"2","key":"4474_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3233\/CBM-190913","volume":"30","author":"D Wu","year":"2021","unstructured":"Wu D, Zhu J, Fu Y, Li C, Wu B. LncRNA HOTAIR promotes breast cancer progression through regulating the miR-129-5p\/FZD7 axis. Cancer Biomark. 2021;30(2):203\u201312.","journal-title":"Cancer Biomark"},{"issue":"12","key":"4474_CR29","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41419-021-04386-0","volume":"12","author":"K Guo","year":"2021","unstructured":"Guo K, Qian K, Shi Y, Sun T, Wang Z. LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p. Cell Death Dis. 2021;12(12):1097.","journal-title":"Cell Death Dis"},{"issue":"7","key":"4474_CR30","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/CAD.0000000000001288","volume":"33","author":"W Fang","year":"2022","unstructured":"Fang W, Xia Y. LncRNA HLA-F-AS1 attenuates the ovarian cancer development by targeting miR-21-3p\/PEG3 axis. Anticancer Drugs. 2022;33(7):671\u201381.","journal-title":"Anticancer Drugs"},{"issue":"9","key":"4474_CR31","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1515\/hsz-2019-0430","volume":"401","author":"C Zhang","year":"2020","unstructured":"Zhang C, Lian H, Xie L, Yin N, Cui Y. LncRNA ELFN1-AS1 promotes esophageal cancer progression by up-regulating GFPT1 via sponging miR-183-3p. Biol Chem. 2020;401(9):1053\u201361.","journal-title":"Biol Chem"},{"issue":"4","key":"4474_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3233\/CBM-190559","volume":"27","author":"R Lei","year":"2020","unstructured":"Lei R, Feng L, Hong D. ELFN1-AS1 accelerates the proliferation and migration of colorectal cancer via regulation of miR-4644\/TRIM44 axis. Cancer Biomark. 2020;27(4):433\u201343.","journal-title":"Cancer Biomark"},{"issue":"7","key":"4474_CR33","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/kjm2.12548","volume":"38","author":"SH Zhuang","year":"2022","unstructured":"Zhuang SH, Meng CC, Fu JJ, Huang J. Long non-coding RNA ELFN1-AS1-mediated ZBTB16 inhibition augments the progression of gastric cancer by activating the PI3K\/AKT axis. Kaohsiung J Med Sci. 2022;38(7):621\u201332.","journal-title":"Kaohsiung J Med Sci"},{"key":"4474_CR34","doi-asserted-by":"crossref","unstructured":"Varghese E, Samuel SM, Sadiq Z, Kubatka P, Liskova A, Benacka J et al. Anti-cancer agents in proliferation and cell death: the calcium connection. Int J Mol Sci. 2019;20(12):3017.","DOI":"10.3390\/ijms20123017"},{"issue":"7","key":"4474_CR35","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.cell.2019.05.026","volume":"177","author":"L Galluzzi","year":"2019","unstructured":"Galluzzi L, Green DR. Autophagy-independent functions of the autophagy machinery. Cell. 2019;177(7):1682\u201399.","journal-title":"Cell"},{"issue":"10","key":"4474_CR36","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1080\/15548627.2017.1343770","volume":"13","author":"A Kuma","year":"2017","unstructured":"Kuma A, Komatsu M, Mizushima N. Autophagy-monitoring and autophagy-deficient mice. Autophagy. 2017;13(10):1619\u201328.","journal-title":"Autophagy"},{"issue":"9","key":"4474_CR37","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/jcb.29536","volume":"122","author":"XF Luan","year":"2021","unstructured":"Luan XF, Wang L, Gai XF. The miR-28-5p-CAMTA2 axis regulates colon cancer progression via Wnt\/\u03b2-catenin signaling. J Cell Biochem. 2021;122(9):945\u201357.","journal-title":"J Cell Biochem"},{"issue":"19","key":"4474_CR38","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1080\/15384101.2022.2085359","volume":"21","author":"T Chen","year":"2022","unstructured":"Chen T, Wang H, Yan H. miR-28-5p inhibits cholangiocarcinoma progression and predicts good prognosis of patients. Cell Cycle. 2022;21(19):2079\u201390.","journal-title":"Cell Cycle"},{"issue":"1","key":"4474_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/dvdy.1169","volume":"222","author":"CL Moulson","year":"2001","unstructured":"Moulson CL, Li C, Miner JH. Localization of Lutheran, a novel laminin receptor, in normal, knockout, and transgenic mice suggests an interaction with laminin alpha5 in vivo. Dev Dyn. 2001;222(1):101\u201314.","journal-title":"Dev Dyn"},{"issue":"2","key":"4474_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00403-004-0481-4","volume":"296","author":"C Drewniok","year":"2004","unstructured":"Drewniok C, Wienrich BG, Sch\u00f6n M, Ulrich J, Zen Q, Telen MJ, et al. Molecular interactions of B-CAM (basal-cell adhesion molecule) and laminin in epithelial skin cancer. Arch Dermatol Res. 2004;296(2):59\u201366.","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"4474_CR41","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1021\/pr800904z","volume":"8","author":"KH Yu","year":"2009","unstructured":"Yu KH, Barry CG, Austin D, Busch CM, Sangar V, Rustgi AK, et al. Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery. J Proteome Res. 2009;8(3):1565\u201376.","journal-title":"J Proteome Res"},{"issue":"1","key":"4474_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.humpath.2010.01.025","volume":"42","author":"J Planagum\u00e0","year":"2011","unstructured":"Planagum\u00e0 J, Liljestr\u00f6m M, Alameda F, B\u00fctzow R, Virtanen I, Revent\u00f3s J, et al. Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1\/AML1 and ETV5\/ERM at the invasive front of endometrial and ovarian carcinoma. Hum Pathol. 2011;42(1):57\u201367.","journal-title":"Hum Pathol"},{"issue":"3","key":"4474_CR43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bcmd.2012.10.009","volume":"50","author":"FR Latini","year":"2013","unstructured":"Latini FR, Bastos AU, Arnoni CP, Muniz JG, Person RM, Baleotti W Jr., et al. DARC (Duffy) and BCAM (Lutheran) reduced expression in thyroid cancer. Blood Cells Mol Dis. 2013;50(3):161\u20135.","journal-title":"Blood Cells Mol Dis"},{"issue":"5","key":"4474_CR44","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1074\/mcp.M500330-MCP200","volume":"5","author":"F Le Naour","year":"2006","unstructured":"Le Naour F, Andr\u00e9 M, Greco C, Billard M, Sordat B, Emile JF, et al. Profiling of the tetraspanin web of human colon cancer cells. Mol Cell Proteom. 2006;5(5):845\u201357.","journal-title":"Mol Cell Proteom"},{"issue":"4","key":"4474_CR45","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/1878-0261.12638","volume":"14","author":"J Jin","year":"2020","unstructured":"Jin J, Xie S, Sun Q, Huang Z, Chen K, Guo D, et al. Upregulation of BCAM and its sense lncRNA BAN are associated with gastric cancer metastasis and poor prognosis. Mol Oncol. 2020;14(4):829\u201345.","journal-title":"Mol Oncol"},{"issue":"11","key":"4474_CR46","doi-asserted-by":"publisher","first-page":"e78716","DOI":"10.1371\/journal.pone.0078716","volume":"8","author":"H Akiyama","year":"2013","unstructured":"Akiyama H, Iwahana Y, Suda M, Yoshimura A, Kogai H, Nagashima A, et al. The FBI1\/Akirin2 target gene, BCAM, acts as a suppressive oncogene. PLoS ONE. 2013;8(11):e78716.","journal-title":"PLoS ONE"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04474-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04474-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04474-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:26:53Z","timestamp":1789514813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04474-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4474"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04474-5","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"373"}}